50,434 Shares in LeMaitre Vascular, Inc. $LMAT Bought by Legal & General Group Plc

Legal & General Group Plc acquired a new stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 50,434 shares of the medical instruments supplier’s stock, valued at approximately $4,840,000.

Several other hedge funds also recently made changes to their positions in LMAT. Sound Income Strategies LLC increased its position in shares of LeMaitre Vascular by 425.6% during the first quarter. Sound Income Strategies LLC now owns 226 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 183 shares in the last quarter. Catalyst Capital Advisors LLC acquired a new stake in shares of LeMaitre Vascular in the 1st quarter valued at about $32,000. Geneos Wealth Management Inc. grew its stake in LeMaitre Vascular by 250.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 557 shares of the medical instruments supplier’s stock worth $47,000 after buying an additional 398 shares during the last quarter. EverSource Wealth Advisors LLC purchased a new position in LeMaitre Vascular during the 2nd quarter worth approximately $47,000. Finally, Quarry LP increased its position in LeMaitre Vascular by 267.2% during the third quarter. Quarry LP now owns 727 shares of the medical instruments supplier’s stock worth $64,000 after buying an additional 529 shares during the period. Hedge funds and other institutional investors own 84.64% of the company’s stock.

Analyst Upgrades and Downgrades

LMAT has been the subject of a number of research reports. Zacks Research cut LeMaitre Vascular from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. Citigroup reaffirmed a “market outperform” rating on shares of LeMaitre Vascular in a report on Tuesday, July 21st. Wall Street Zen downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings cut shares of LeMaitre Vascular from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, August 14th. Finally, Wells Fargo & Company lowered their price objective on shares of LeMaitre Vascular from $104.00 to $94.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, LeMaitre Vascular has an average rating of “Hold” and an average target price of $110.60.

LeMaitre Vascular Stock Down 1.5%

LeMaitre Vascular stock opened at $80.49 on Friday. The stock has a 50 day moving average of $92.18 and a two-hundred day moving average of $99.23. LeMaitre Vascular, Inc. has a twelve month low of $78.27 and a twelve month high of $118.01. The stock has a market capitalization of $1.84 billion, a price-to-earnings ratio of 28.24, a PEG ratio of 2.36 and a beta of 0.50. The company has a current ratio of 16.31, a quick ratio of 13.96 and a debt-to-equity ratio of 0.40.

LeMaitre Vascular (NASDAQ:LMAT) last released its earnings results on Tuesday, August 4th. The medical instruments supplier reported $0.74 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.07). LeMaitre Vascular had a net margin of 25.02% and a return on equity of 15.63%. The company had revenue of $70.38 million during the quarter, compared to analyst estimates of $71.47 million. During the same period in the previous year, the firm posted $0.60 EPS. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. As a group, research analysts expect that LeMaitre Vascular, Inc. will post 2.89 earnings per share for the current year.

LeMaitre Vascular Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Thursday, August 20th were given a dividend of $0.25 per share. The ex-dividend date was Thursday, August 20th. This represents a $1.00 dividend on an annualized basis and a yield of 1.2%. LeMaitre Vascular’s dividend payout ratio is presently 35.09%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.